Takashi Yamane

8PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityAllergyClinical chemistry (incl. diagnostics)Plant pathology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 05, 2026
Real-world retention of nintedanib and factors associated with treatment discontinuation in connective tissue disease-associated interstitial lung disease: a retrospective cohort study of 92 patients.

|Dec 01, 2025
Glucocorticoid-free remission with simultaneous mepolizumab and rituximab in life-threatening PR3-ANCA-positive eosinophilic granulomatosis with polyangiitis: a case report and literature review.

Takashi Yamane, Ayaka Inoue, Chihiro Ichikawa

|Apr 21, 2025
Risks of empiric glucocorticoid administration in elderly patients with inflammation of unknown origin: A case report.

Takashi Yamane, Chiharu Miyamoto

|Jan 31, 2025
Generalized Edema in Anti-NXP2 Antibody-Positive Dermatomyositis.

Yuki Koshida, Takashi Yamane

|Sep 27, 2024
Successful treatment of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease complicated by bilateral breast cancer following the additional tofacitinib: A case report.

Takashi Yamane, Midori Kitayama

|Mar 21, 2024
Initiation of belimumab with higher daily prednisolone is effective for rapid glucocorticoid reduction: A 96-week retrospective study.

Takashi Yamane, Akira Hashiramoto

Pageof 2

Frequent Collaborators

1 joint publications

Yuki Koshida